Dr. Sundaresan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Fruit St
Yawkey 7b
Boston, MA 02114Phone+1 617-632-3779
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2011 - 2014
University of California (San Francisco)Residency, Internal Medicine, 2008 - 2011
Rutgers Robert Wood Johnson Medical SchoolClass of 2008
Certifications & Licensure
CA State Medical License 2010 - 2026
MA State Medical License 2011 - 2018
Publications & Presentations
PubMed
- Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma.Jordan M Cloyd, Angela Sarna, Matthew J Arango, Susan E Bates, Manoop S Bhutani
JAMA Surgery. 2024-12-04 - 1 citationsDevelopmental mosaicism underlying EGFR-mutant lung cancer presenting with multiple primary tumors.Risa Burr, Ignaty Leshchiner, Christina L Costantino, Martin Blohmer, Tilak Sundaresan
Nature Cancer. 2024-11-01 - Germline mutations and developmental mosaicism underlying-mutant lung cancer.Risa Burr, Ignaty Leshchiner, Christina L Costantino, Martin Blohmer, Tilak Sundaresan
Medrxiv. 2023-09-29
Press Mentions
Blood Test May One Day Predict Breast Cancer RelapseAugust 26th, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
